secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solana Co (HSDT)
CIK:        0001610853
Form:       8-K
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0001558370-25-009304
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Helius Medical reports positive PoNS Stroke Registrational Program results; FDA submission planned
--------------------------------------------------------------------------------

- Double-blind RCT met primary endpoint: statistically significant improvements in gait/balance with active PoNS therapy (with/without open-label data).
- 159 patients enrolled across three studies; 130 completed 12-week treatment and follow-up at 10 US/Canada sites.
- Minimal adverse events and good tolerability confirmed; key secondary endpoints on fall risk and durability met.
- Company plans FDA submission for gait/balance deficit indication in chronic stroke under Breakthrough Device Designation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610853/000155837025009304/0001558370-25-009304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610853/000155837025009304/hsdt-20250721x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-009304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer